Product Description
Product introduction
Platepag ML 25mg Tablet is used to treat low platelet count due to chronic immune (idiopathic) thrombocytopenic purpura (ITP) or chronic hepatitis C virus (HCV) infection. It is also used to treat severe aplastic anemia.
Platepag ML 25mg Tablet is a thrombopoietin agonist. It works by stimulating the formation of new platelets in the blood. The function of platelets is to help reduce bleeding.
Take it in the exact dose and duration as advised by the doctor. You may take it on an empty stomach. This medicine is to be swallowed as a whole. Do not chew, crush or break it. Inform your doctor if you have any known allergies to this medication.
The common side effects include nausea, vomiting, diarrhea, upper respiratory tract infection, and urinary tract infection. Let your doctor know if any of these side effects bother you. They may be able able to suggest ways to reduce or treat the symptoms.
Before you take this medicine, inform your doctor if you have any preexisting medical conditions. Let your doctor also know about all the other medicines you are taking. Dose adjustments may be required in patients with liver diseases, inform your doctor.
Effective Management of Chronic ITPPlatepag ML is specifically formulated for adults suffering from chronic immune thrombocytopenia, providing a targeted approach to increase platelet counts. By acting on thrombopoietin receptors, it helps reduce the risk of bleeding episodes associated with low platelets, thus improving patient outcomes. The medication is available in convenient tablet form, each containing 25 mg of eltrombopag, and comes in boxes of 28 tablets to support continuous therapy as prescribed.
Prescription-Based and Professionally SupervisedPlatepag ML Tablets require a valid prescription and regular supervision by a medical professional. This ensures that dosage, possible side effects, and liver function are closely monitored. The medicine is not intended for self-administration or use in individuals with severe hepatic impairment without medical oversight, thereby prioritizing patient safety and therapeutic effectiveness.
FAQ's of Platepag ML 25 Mg Tablets:
Q: How does Platepag ML 25 Mg Tablet benefit patients with chronic immune thrombocytopenia?
A: Platepag ML 25 Mg Tablet helps increase platelet production by acting as a thrombopoietin receptor agonist, reducing the risk of bleeding episodes in adults with chronic immune thrombocytopenia (ITP).
Q: What is the recommended way to take Platepag ML Tablets?
A: The recommended administration is to take the tablet orally as prescribed by your physician, usually once daily. Follow your doctor's instructions carefully regarding dosage and timing.
Q: When should I avoid using Platepag ML Tablets?
A: Platepag ML should not be used by individuals with known hypersensitivity to eltrombopag or any excipients, or those with severe hepatic impairment without medical supervision.
Q: Where should I store Platepag ML Tablets for best efficacy?
A: Store Platepag ML Tablets in a cool, dry place below 30C, away from light and moisture, to maintain their effectiveness throughout the 24-month shelf life.
Q: What side effects may occur while using Platepag ML Tablets?
A: Common side effects may include nausea, diarrhea, headache, fatigue, and increased liver enzymes. Consult your doctor if you experience any persistent or severe symptoms.
Q: How is liver function monitored during Platepag ML treatment?
A: Regular monitoring of liver function is recommended during treatment. Your physician will schedule periodic tests to assess liver enzymes and ensure safe, ongoing use.
Q: What should I do if I miss a dose of Platepag ML Tablets?
A: If you miss a dose, take it as soon as you remember unless it is close to your next scheduled dose. Do not double up to make up for the missed tablet-consult your physician for guidance.